Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Sarclisa

Hematology

Hematology Today—April 27, 2026

This week’s Hematology update highlights regulatory approvals, extended review…

Hematology

Hematology Today—March 30, 2026

This week’s Hematology update highlights regulatory progress, evolving…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Respiratory Today—May 15, 2026
Vaccines Today—May 15, 2026
Public Health Today—May 15, 2026
Lucid Diligence Brief: Iterative Health Acquisition of NextStage Cardiology Research Sites
Lucid Diligence Brief: ERS Genomics and Aurigene CRISPR/Cas9 License

Tags

Affera Chronic disease mortality Citius Oncology conduction-system pacing cost reduction DIPS Arena Enzalutamide FDA Digital Health Advisory FG001 FreeStyle Libre Gateway Labs GLP-1 Receptor Agonists gout flares Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Insulin Efsitora Alfa Jaypirca King’s College London Limb-Girdle Muscular Dystrophy Type R5 live biotherapeutic product Liver Metastasis MicroRNAs MTAP-Deleted Solid Tumors naxtarubicin NewcelX OCALIVA oncology clinical trials oral therapeutics Palvella Therapeutics payer mix Peptron POLY-ACS PPMS Pre-MIRACLE2 Rinvoq Rituximab Spikevax Stanford Medicine Sutra Medical Telix Pharmaceuticals TG Therapeutics Therna Biosciences trained immunity Transgene Ver-A-T1D Watchman FLX

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Respiratory Today—May 15, 2026
Vaccines Today—May 15, 2026
Public Health Today—May 15, 2026
Lucid Diligence Brief: Iterative Health Acquisition of NextStage Cardiology Research Sites
Lucid Diligence Brief: ERS Genomics and Aurigene CRISPR/Cas9 License

TAGS

Affera Chronic disease mortality Citius Oncology conduction-system pacing cost reduction DIPS Arena Enzalutamide FDA Digital Health Advisory FG001 FreeStyle Libre Gateway Labs GLP-1 Receptor Agonists gout flares Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Insulin Efsitora Alfa Jaypirca King’s College London Limb-Girdle Muscular Dystrophy Type R5 live biotherapeutic product Liver Metastasis MicroRNAs MTAP-Deleted Solid Tumors naxtarubicin NewcelX OCALIVA oncology clinical trials oral therapeutics Palvella Therapeutics payer mix Peptron POLY-ACS PPMS Pre-MIRACLE2 Rinvoq Rituximab Spikevax Stanford Medicine Sutra Medical Telix Pharmaceuticals TG Therapeutics Therna Biosciences trained immunity Transgene Ver-A-T1D Watchman FLX

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy